Find helpful resources about Boston Scientific’s Drug-Eluting Technologies.

Anchor component is added but not authored

Case Study Videos

The video shows the diagnostic work-up with antegrade infusion, which finds a heavily diseased right SFA and short sub-total occlusion of an existing stent. 

January 18, 2017

Advances in Drug-Eluting Technologies used for the treatment of coronary artery disease have been adapted for application in chronic peripheral lesions.

January 18, 2017



Watch leading physicians discuss how drug-eluting therapies are revolutionizing the treatment of SFA lesions.

September 9, 2016

Expert Commentary


Watch Dr. Juan Granada discuss the latest Ranger preclinical data confirming the benefit of optimized drug transfer.

September 22, 2016

Read the article on Drug Delivery written by Prof. Stefan Müller-Hülsbeck: Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

January 26, 2017

Product Videos and Animation

Learn about Eluvia's unique polymer-based technology designed to sustain drug release to match restenosis in the SFA.

September 9, 2016

Learn about Ranger's innovative TransPax coating technology.

September 9, 2016

Discover how the Eluvia Stent was designed and engineered to solve the unique challenge of restenosis in the SFA.

September 9, 2016

Discover how the Ranger™ coating technology (TransPax) is designed to deliver a therapeutic drug dose consistently and efficiently to the lesion.

September 9, 2016



Download the summary of the exceptional clinical data results from Ranger™ SFA trial and Ranger™ all comers Registry.

October 25, 2016